Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11622 results
-
Allied Health Industry Reference Group meeting summaries
This collection contains meeting summaries from the Allied Health Industry Reference Group. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix C – Modified MRC respiratory questionnaire
This questionnaire helps general practitioners assess workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix D – Modified MRC dyspnoea scale
This scale helps general practitioners assess workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix E – Spirometry case study
This case study shows how to appropriately determine a change in spirometry over time in an individual exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Administrative report
This administrative report outlines how the National Dust Disease Taskforce developed national guidance for doctors assessing workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust
The national guidance and associated documents provide a framework to identify workers exposed to respirable crystalline silica dust, and supports medical practitioners to carry out health surveillance within their specific training and experience. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust
The national guidance provides a framework to identify workers exposed to respirable crystalline silica dust and support medical practitioners carry out health surveillance within their specific training and experience. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Summary
The document summarises the national guidance for doctors assessing workers exposed to respirable crystalline silica dust. -
National Guidance for doctors assessing workers exposed to respirable crystalline silica dust – Practice guide
This practice guide provides medical practitioners with guidance on identifying and assessing workers exposed to respirable crystalline silica dust, and carrying out health assessments and surveillance. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix A – Exposure Risk Matrix
This exposure risk matrix assists medical practitioners assess workers exposed to respirable crystalline silica dust. -
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix B – Shared decision making tool
This decision aid helps patients exposed to respirable crystalline silica (RCB) dust decide their next steps, including if they should keep working. -
Coronavirus (COVID-19) at a glance – 27 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 27 February 2022 -
Coronavirus (COVID-19) at a glance – 26 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 26 February 2022 -
Coronavirus (COVID-19) at a glance – 25 February 2022
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 25 February 2022 -
Clinical Advisory Committee advice: Consistent protocols on radial scars
BreastScreen Australia Clinical Advisory Committee endorsed advice regarding the management of Radial Scar/Complex Sclerosing Lesion. -
Aged care funding instrument (ACFI) monitoring report – November 2021
This report shows the monthly growth in ACFI subsidies compared to estimates for November 2021. -
Council of Elders communique – 18 February 2022
An update from the Council of Elders after their meeting on 18 February 2022. -
COVID-19 vaccine rollout update – 28 February 2022
This presentation, delivered on 28 February 2022, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 28 February 2022
This data file contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 vaccination – Local Government Area (LGA) – 28 February 2022
This report lists the percentage of people who have been vaccinated against COVID-19, by Local Government Area. The percentages are further broken down by geographic regions and whether they've had one dose or are fully vaccinated. -
Healthcare Identifiers Act and Service Review – Final report, November 2018
This review considered any legislative, operational or administrative barriers that may interfere with the Healthcare Identifiers Act achieving its objectives. It makes recommendations to improve performance against the objectives of the Act. -
Human immunodeficiency virus – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for human immunodeficiency virus. -
COVID-19 vaccine rollout update – 27 February 2022
This presentation, delivered on 27 February 2022, contains an update to Australia's COVID-19 vaccine rollout. -
COVID-19 vaccination – vaccination data – 27 February 2022
This data file contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 vaccine rollout update – 26 February 2022
This presentation, delivered on 26 February 2022, contains an update to Australia's COVID-19 vaccine rollout.